Akerna Corp Cl A (KERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KERN | ABT | SYK | BSX | MDT |
| Company | Akerna Corp Cl A | Abbott Laboratories | Stryker Corp | Boston Scientific Corp | Medtronic Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NYSE |
| Open | 5.0320 | 115.68 | 387.19 | 90.65 | 84.20 |
| High | 6.4000 | 117.64 | 390.37 | 91.72 | 85.13 |
| Low | 5.0000 | 115.14 | 384.57 | 90.23 | 83.92 |
| Last | 6.2720 | 117.26 | 390.14 | 91.50 | 84.74 |
| Change | +1.6920 | +1.33 | +4.46 | +1.33 | +0.63 |
| % Change | +36.94% | +1.15% | +1.16% | +1.47% | +0.75% |
| Volume | 70,795 | 5,561,983 | 1,136,393 | 4,195,172 | 5,699,805 |
| 20-Day Average Volume | 366,650 | 5,430,475 | 1,498,830 | 6,442,255 | 6,715,840 |
| Previous Close | 4.5800 | 115.93 | 385.68 | 90.17 | 84.11 |
| Industry | Medical Products | Medical Products | Medical Products | Medical Products | Medical Products |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3062 | 115.99 | 374.39 | 87.03 | 88.29 |
| 20-Day Raw Stochastic | 52.53% | 56.00% | 82.82% | 98.01% | 14.03% |
| 20-Day Relative Strength | 49.76% | 54.13% | 64.76% | 68.42% | 38.64% |
| Weighted Alpha | -68.12 | +13.81 | +33.10 | +63.31 | +5.08 |
| Today's Opinion | 40% Sell | 100% Buy | 100% Buy | 100% Buy | 24% Buy |
| Previous Opinion | 72% Sell | 88% Buy | 100% Buy | 100% Buy | 8% Sell |
| Last Month's Opinion | 8% Sell | 88% Buy | 96% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.54% since 02/01/24 | +1.94% since 11/14/24 | +1.79% since 11/14/24 | +4.46% since 11/14/24 | -1.47% since 11/14/24 |
| Low | 0.2180 on 02/07/24 | 114.43 on 11/15/24 | 380.21 on 11/15/24 | 86.01 on 11/15/24 | 83.55 on 11/20/24 |
| High | 0.3400 on 02/02/24 | 117.94 on 11/18/24 | 398.20 on 11/18/24 | 91.72 on 11/21/24 | 88.72 on 11/18/24 |
| 1-Month | |||||
| %Chg | -16.79% since 01/08/24 | +0.23% since 10/21/24 | +6.23% since 10/21/24 | +3.92% since 10/21/24 | -6.91% since 10/21/24 |
| Low | 0.2180 on 02/07/24 | 112.50 on 10/30/24 | 351.29 on 10/25/24 | 80.64 on 10/30/24 | 83.55 on 11/20/24 |
| High | 0.4000 on 01/26/24 | 121.00 on 11/06/24 | 398.20 on 11/18/24 | 91.72 on 11/21/24 | 92.68 on 10/24/24 |
| 3-Month | |||||
| %Chg | +20.66% since 11/08/23 | +5.27% since 08/21/24 | +12.98% since 08/21/24 | +16.10% since 08/21/24 | -3.20% since 08/21/24 |
| Low | 0.2180 on 02/07/24 | 111.05 on 08/22/24 | 343.95 on 10/07/24 | 78.53 on 08/23/24 | 83.55 on 11/20/24 |
| High | 0.5150 on 12/28/23 | 121.00 on 11/06/24 | 398.20 on 11/18/24 | 91.72 on 11/21/24 | 92.68 on 10/24/24 |
| 6-Month | |||||
| %Chg | -33.28% since 08/08/23 | +13.89% since 05/21/24 | +18.04% since 05/21/24 | +20.92% since 05/21/24 | -0.50% since 05/21/24 |
| Low | 0.1700 on 09/28/23 | 99.71 on 07/18/24 | 314.93 on 08/05/24 | 71.88 on 08/05/24 | 75.96 on 07/09/24 |
| High | 0.5150 on 12/28/23 | 121.00 on 11/06/24 | 398.20 on 11/18/24 | 91.72 on 11/21/24 | 92.68 on 10/24/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,246 | 201,075,360 | 147,027,392 | 132,894,976 | 107,868,304 |
| Shares Outstanding, K | 10,352 | 1,734,455 | 381,216 | 1,473,827 | 1,282,467 |
| Annual Sales | 13,650,000 | 40,109,000,000 | 20,498,000,000 | 14,240,000,000 | 32,364,000,000 |
| Annual Net Income | -79,060,000 | 5,723,000,000 | 3,165,000,000 | 1,591,000,000 | 3,677,000,000 |
| Last Quarter Sales | 2,080,000 | 10,635,000,000 | 5,494,000,000 | 4,209,000,000 | 7,915,000,000 |
| Last Quarter Net Income | -2,590,000 | 1,646,000,000 | 834,000,000 | 468,000,000 | 1,043,000,000 |
| 60-Month Beta | 3.02 | 0.72 | 0.91 | 0.79 | 0.84 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 11/14/23 | 1.21 on 10/16/24 | 2.87 on 10/29/24 | 0.63 on 10/23/24 | 1.26 on 11/19/24 |
| Latest Earnings Date | 03/19/24 | 10/16/24 | 10/29/24 | 10/23/24 | 11/19/24 |
| Most Recent Dividend | N/A | 0.550 on 10/15/24 | 0.800 on 09/30/24 | N/A | 0.700 on 09/27/24 |
| Next Ex-Dividends Date | N/A | 10/15/24 | 09/30/24 | N/A | 09/27/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.91 | 33.39 | 38.28 | 16.19 |